AlanMyerTennenbergMD

PubMed

• Levofloxacin 750-mg for 5 days for the treatment of hospitalized Fine Risk Class III/IV community-acquired pneumonia patients.
  Shorr, A. F., Khashab, M. M., Xiang, J. X., Tennenberg, A. M., Kahn, J. B.> ;Respiratory medicine. 2006 May 30
• 6 citations
  Pneumonia due to Pseudomonas aeruginosa: the levofloxacin clinical trials experience.
  Tennenberg, A. M., Davis, N. B., Wu, S., Kahn, J. B.> ;Current medical research and opinion. 2006 May 20
• 26 citations
  A multicenter, randomized, double-blind, retrospective comparison of 5- and 10-day regimens of levofloxacin in a subgroup of patients aged > or =65 years with communit...
  Shorr, A. F., Zadeikis, N., Xiang, J. X., Tennenberg, A. M., Ely, E. W.> ;Clinical therapeutics. 2005 Oct 4
• Levofloxacin for treatment of ventilator-associated pneumonia: a subgroup analysis from a randomized trial.
  Andrew F. Shorr, Neringa Zadeikis, William L. Jackson, Anthony S. Ramage, Shu-Chen Wu, Alan M. Tennenberg, Marin H. Kollef> ;Clinical Infectious Diseases. 2005 Feb 15
• Clinical implications of 750 mg, 5-day levofloxacin for the treatment of community-acquired pneumonia.
  Thomas M. File, Gary Milkovich, Alan M. Tennenberg, Jim Xiang, Mohammed M. Khashab, Neringa Zadeikis> ;Current Medical Research and Opinion. 2004 Jul 28
• 45 citations
  Levofloxacin efficacy in the treatment of community-acquired legionellosis.
  Yu, V. L., Greenberg, R. N., Zadeikis, N., Stout, J. E., Khashab, M. M., Olson, W. H., Tennenberg, A. M.> ;Chest. 2004 Jun 11
• 61 citations
  Efficacy of 750-mg, 5-day levofloxacin in the treatment of community-acquired pneumonia caused by atypical pathogens.
  Dunbar, L. M., Khashab, M. M., Kahn, J. B., Zadeikis, N., Xiang, J. X., Tennenberg, A. M.> ;Current medical research and opinion. 2004 May 4
• 158 citations
  High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm.
  Lala M. Dunbar, Richard G. Wunderink, Michael P. Habib, Leon G. Smith, Alan M. Tennenberg, Mohammed M. Khashab, Barbara A. Wiesinger, Jim Xiang, Neringa Zadeikis, Jame...> ;Clinical Infectious Diseases. 2003 Sep 15
• 48 citations
  Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: a randomized double-blind multicenter study.
  Bundrick, W., Heron, S. P., Ray, P., Schiff, W. M., Tennenberg, A. M., Wiesinger, B. A., Wright, P. A., Wu, S., Zadeikis, N., Kahn, J. B.> ;Urology. 2003 Aug 30
• 4 citations
  A multicenter, open-label, randomized comparison of levofloxacin and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community-acquired pn...
  Frank, E., Liu, J., Kinasewitz, G. T., Moran, G. J., Oross, M. P., Olson, W. H., Reichl, V., Freitag, S., Bahal, N., Wiesinger, B. A., Tennenberg, A. M., Kahn, J. B.> ;Clinical therapeutics. 2002 Sep 21
• Join now to see all